The rollout of Covid-19 vaccines in the US and Europe and growing evidence of their effectiveness means a rally in value stock still has further to go, analysts at Bank of America said.

The 12 March client note cited studies in Israel and the UK that showed a single vaccine dose can reduce the risk of being hospitalised by more than 80% across all age groups.